U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,731 records

Showing results for "secondary".

  1. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
    December 11, 2012 - Peer Reviewer #3 Introduction This report does not deal with ascending testes (secondary or acquired … gradually emerged that testes that are operated on later in childhood have progressively more severe secondary

  2. Confidential Physician Feedback Reports: Designing for Optimal Impact on Performance (pdf file)

    www.ahrq.gov/sites/default/files/publications/files/confidreportguide_1.pdf
    March 01, 2016 - vi A secondary aim is to foster discussion among report developers, the broader quality improvement … a report before release, be it via cognitive or semistructured interviews or focus groups, has a secondary … documentation available as online appendixes. 28 Confidential Physician Feedback Reports A secondary

  3. 2002 HCUP Nationwide Inpatient Sample (NIS) Comparison Report

    hcup-us.ahrq.gov/db/nation/nis/reports/2002niscomparisonrpt.jsp
    June 01, 2016 - the NHDS was as follows: if a symptom appeared as a first-listed code and a diagnosis appeared as a secondary … If a symptom appeared as a first-listed code and a diagnosis was listed as a secondary code, the diagnosis … NIS records to MedPAR data, only the NIS discharges for which Medicare was the expected primary or secondary … For example, when a symptom appeared as the first-listed code, the NHDS re-assigned the symptom as a secondary … both fee-for-service and managed care) for which Medicare was the expected payer (either primary or secondary

  4. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
    July 05, 2005 - these studies found that the cost-effectiveness improved to $15,000 per quality-adjusted life-year when secondary … lower than seen in the general population. 242 The other study, which did not directly incorporate secondary … The study by Sanders and colleagues found that the model was sensitive to the effects of screening on secondary … Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion … † Includes studies of secondary prophylaxis. Return to Table of Contents Table 3.

  5. Maskedstats Nis 2020 Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_Weighted_V2.PDF
    January 01, 2020 - Distribution for DRG_NOPOA DRG_NoPOA Frequency Percent of Total 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 15,690 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 73,305 0.23% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 2,715

  6. Maskedstats Nis 2022 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core_Weighted.PDF
    January 01, 2022 - DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 1,015 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 17,710 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 68,550 0.21% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 2,325

  7. Maskedstats Nis 2021 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core_Weighted.PDF
    January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 985 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 16,170 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 72,325 0.22% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 2,285

  8. Maskedstats Nis 2018 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
    January 01, 2018 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,440 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 17,880 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 82,390 … Distribution for DRG_NOPOA DRG_NoPOA Frequency Percent of Total 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY

  9. Maskedstats Nis 2018 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
    January 01, 2018 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 288 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,576 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 16,478 … Distribution for DRG_NOPOA DRG_NoPOA Frequency Percent of Total 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY

  10. Maskedstats Nis 2019 Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,440 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 16,000 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 83,400 … 0.24% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 3,660 0.01% 849: RADIOTHERAPY

  11. Maskedstats Nrd 2017 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core_Weighted.PDF
    January 01, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,568 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 17,375 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 84,355 … 0.24% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 4,125 0.01% 849: RADIOTHERAPY

  12. Maskedstats Nrd 2021 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_Core_Weighted.PDF
    January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 974 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 16,176 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 70,935 0.21% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 1,992

  13. Maskedstats Nrd 2016 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core_Weighted.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,780 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 15,715 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 91,259 … 0.26% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 5,525 0.02% 849: RADIOTHERAPY

  14. Maskedstats Nrd 2018 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core_Weighted.PDF
    January 01, 2018 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,409 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 17,029 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 79,179 … 0.22% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 3,586 0.01% 849: RADIOTHERAPY

  15. Kid 2019 Maskedstats Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 87 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,806 0.06% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 24,869 … 0.42% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,423 0.02% 849: RADIOTHERAPY

  16. Kid 2016 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 129 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,680 0.06% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 27,214 … 0.43% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,956 0.03% 849: RADIOTHERAPY

  17. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - has been reported, there are approaches to identification of the highest risk individuals even in secondary … Statins do not address these secondary goals, and combination therapies have been shown to be useful … added combo therapy have not shown “hard” endpoint benefit, but have been seen as effective for secondary

  18. National Web-Based Teleconference on Health IT and Safety - Using Health IT to Prevent Adverse Events (pdf file)

    digital.ahrq.gov/sites/default/files/docs/Health_IT_and_Safety_070910_comp.pdf
    July 13, 2010 - of time spent on medication administration did not change after barcode/eMAR implementation • Secondary

  19. A National Web Conference on the Role of Telehealth to Increase Access to Care and Improve Healthcare Quality - Slides (pdf file)

    digital.ahrq.gov/sites/default/files/docs/telehealth-slides-06092020.pdf
    June 09, 2020 - Primary outcome was the psychiatrist-completed Clinical Global Impressions (CGI) severity (6 months) • Secondary

  20. Radiotherapy-Proton-Beam Research (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
    May 01, 2012 - ) Conditions of possible benefit (Group 2) Intraocular melanomas Benign or malignant primary and secondary
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1194)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (718)

digital.ahrq.gov (414)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (13)

meps.ahrq.gov (7)

integrationacademy.ahrq.gov (5)

datatools.ahrq.gov (3)

qualityindicators.ahrq.gov (3)

pso.ahrq.gov (2)